SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare Medical Dialogues Bureau27 Aug 2019 9:45 AM ISTFounder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
CDSCO preparing list of dual-use APIs imported from unregistered firms Medical Dialogues Bureau26 Aug 2019 2:23 PM IST"The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
Alkem Labs gets 4 USFDA observations for St Louis facility Medical Dialogues Bureau26 Aug 2019 12:39 PM ISTNew Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
Lupin, Glenmark recall hypertension, fungal infection drugs from US market Medical Dialogues Bureau26 Aug 2019 9:45 AM ISTNew Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
GSK Belantamab Mafodotin shows to help blood cancer patients Medical Dialogues Bureau26 Aug 2019 9:15 AM ISTTwo doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
OxyContin maker Purdue Pharma agrees to provide proprietary research, other data Medical Dialogues Bureau25 Aug 2019 9:00 AM ISTOKLAHOMA CITY: The maker of the powerful painkiller OxyContin has agreed to provide access to proprietary research and other data to researchers at...
Lupin unveils generic version of Prozac tablets in US Medical Dialogues Bureau24 Aug 2019 9:45 AM ISTFluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
Oklahoma judge to rule in opioid lawsuit against JnJ Medical Dialogues Bureau24 Aug 2019 9:10 AM ISTLawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
Allergan, Endo agree to USD 15 million settlement in major opioid case Medical Dialogues Bureau24 Aug 2019 9:00 AM ISTAllergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers Medical Dialogues Bureau23 Aug 2019 12:27 PM ISTNew Delhi: In a move to regularise Fixed Dose Combinations (FDCs), the Central Drugs Standard Control Organization (CDSCO) has notified the process to...
Granules India gets 2 USFDA observations for Chantilly facility Medical Dialogues Bureau23 Aug 2019 11:46 AM IST"The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group Medical Dialogues Bureau22 Aug 2019 9:50 AM IST"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo-ALA Co Ltd....
